Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T22:19:18.118Z.
Consensus retrieved: 2026-10-06T17:57:17.529Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T22:19:18.118Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 64b8b41d6b5635a3630374b271ba93e5d0b13f976b61d7cdc588ead55f2777d6
Forward PE Ratio (N/A) = Dated Quote Price ($0.15) / Consensus Forward EPS ($-1.02)
FORWARD PE RATIO
N/A
Vivos Therapeutics, Inc.
Market Cap
$2.14M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | $2.14M | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.37M | N/A |
| Onconetix, Inc. (ONCO)vs › | $2.37M | N/A |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.38M | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.38M | N/A |
| Autonomix Medical, Inc. (AMIX)vs › | $1.88M | N/A |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.88M | N/A |
| Tenon Medical, Inc. (TNON)vs › | $1.84M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $0.15, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-1.02 | $-1.07 – $-0.98 | 3 | n/m |
| 2027-12-31 | $-0.15 | $-0.17 – $-0.13 | 2 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
